Pharma & Biotech

Enochian Biosciences is executing a strategic pivot to become an artificial intelligence-powered biotechnology firm. Through a new oncology collaboration and...

Rockwell Medical is intensifying its efforts to solidify its presence within the competitive U.S. healthcare sector. The company's recent success...

Oruka Therapeutics is set to increase its engagement with the investment community through a series of high-profile appearances. The biotechnology...

Inotiv has released its financial results for the first quarter of fiscal year 2026, revealing a concerning trend of expanding...

The publicly traded chapter for CureVac has officially closed. The mRNA specialist's shares have ceased trading on public exchanges after...

Shares of the Danish pharmaceutical giant Novo Nordisk surged by more than 8% on Monday. This significant gain followed a...

The year 2026 represents a critical period for Cellectar Biosciences as it advances its radiopharmaceutical pipeline toward key commercial and...

Eli Lilly has delivered a powerful statement with its latest financial results, sharply contrasting with recent warnings from its key...

The new year has brought both significant momentum and fresh challenges for Jasper Therapeutics. The biopharmaceutical company is navigating a...

Precision BioSciences Inc (DTIL) is navigating a period of pronounced market skepticism following a difficult trading week. Although the company's...